PALLANTE, PIERLORENZO
 Distribuzione geografica
Continente #
NA - Nord America 936
EU - Europa 342
AS - Asia 151
AF - Africa 21
Totale 1.450
Nazione #
US - Stati Uniti d'America 924
IT - Italia 139
CN - Cina 99
NL - Olanda 63
SE - Svezia 40
IE - Irlanda 33
FI - Finlandia 29
VN - Vietnam 29
CI - Costa d'Avorio 21
UA - Ucraina 18
HK - Hong Kong 13
CA - Canada 12
DE - Germania 12
GB - Regno Unito 6
IN - India 5
KR - Corea 2
ES - Italia 1
ID - Indonesia 1
IR - Iran 1
JP - Giappone 1
RO - Romania 1
Totale 1.450
Città #
Chandler 263
Ashburn 122
Amsterdam 63
Millbury 44
Beijing 38
Napoli 32
Princeton 32
Dong Ket 28
Jacksonville 25
Naples 25
Nanjing 24
Woodbridge 20
Des Moines 19
Washington 17
Boston 15
Hong Kong 13
Ottawa 12
Wilmington 12
Ann Arbor 11
Aversa 10
Nanchang 10
Lawrence 7
Jiaxing 6
Boardman 5
Milan 5
Seattle 5
Shenyang 5
Falls Church 4
Hebei 4
Kronberg 4
Tianjin 4
Changsha 3
Fremont 3
Indiana 3
Kunming 3
Norwalk 3
San Mateo 3
Bagnoli Irpino 2
Caivano 2
Caserta 2
New York 2
Pozzuoli 2
Torino 2
Ardabil 1
Buffalo 1
Calvizzano 1
Casapulla 1
Castelvetere sul Calore 1
Dublin 1
Fairfield 1
Hangzhou 1
Hanoi 1
Hanover 1
Jakarta 1
Lanzhou 1
Leawood 1
Marano Di Napoli 1
Marigliano 1
Monmouth Junction 1
Monte Di Procida 1
Mumbai 1
Nashville 1
New Delhi 1
Pune 1
Redwood City 1
Romford 1
Salerno 1
San Francisco 1
Scafati 1
Tokyo 1
Torre Del Greco 1
Troina 1
Valencia 1
Yellow Springs 1
Totale 945
Nome #
Analysis of miRNA profiles identified miR-196a as a crucial mediator of aberrant PI3K/AKT signaling in lung cancer cells 70
UbcH10 overexpression may represent a marker of anaplastic thyroid carcinomas 67
HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity 66
Setting up and exploitation of a nano/technological platform for the evaluation of HMGA1b protein in peripheral blood of cancer patients 63
CBX7 and HMGA1b proteins act in opposite way on the regulation of the SPP1 gene expression 52
PATZ1 acts as a tumor suppressor in thyroid cancer via targeting p53-dependent genes involved in EMT and cell migration 51
New somatic mutations and WNK1-B4GALNT3 gene fusion in papillary thyroid carcinoma 51
HMGA1 overexpression is associated with a particular subset of human breast carcinomas 50
The Metallophosphoesterase-Domain-Containing Protein 2 (MPPED2) Gene Acts as Tumor Suppressor in Breast Cancer 48
Editorial: Second Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological and Molecular Aspects of Novel Promising Drugs 45
UbcH10 expression in human lymphomas. 44
The Long Non-Coding RNA Prader Willi/Angelman Region RNA5 (PAR5) Is Downregulated in Anaplastic Thyroid Carcinomas Where It Acts as a Tumor Suppressor by Reducing EZH2 Activity 41
The cl2/dro1/ccdc80 null mice develop thyroid and ovarian neoplasias 40
UbcH10 expression can predict prognosis and sensitivity to the antineoplastic treatment for colorectal cancer patients 40
The loss of the CBX7 gene expression represents an adverse prognostic marker for survival of colon carcinoma patients. 39
CBX7 is a tumor suppressor in mice and humans. 39
CDH-16 gene expression in thyroid cell differentiation and transformation 38
High mobility group a proteins as tumor markers 38
Restoration of CBX7 expression increases the susceptibility of human lung carcinoma cells to irinotecan treatment 36
CBX7 modulates the expression of genes critical for cancer progression. 35
CBX7 Expression in Oncocytic Thyroid Neoplastic Lesions (Hürthle Cell Adenomas and Carcinomas) 34
MicroRNA deregulation in human thyroid papillary carcinomas. 33
miR-191 down-regulation plays a role in thyroid follicular tumors through CDK6 targeting. 33
From protein-protein interaction to E2 inhibitors leads: identification of peptide binding of UbcH10 33
Circulating tumour cells in predictive molecular pathology: Focus on drug-sensitive assays and 3D culture 33
The tyrosine phosphatase PTPRJ/DEP-1 genotype affects thyroid carcinogenesis. 32
CDH-16 gene expression in thyroid cell differentiation and transformation. 32
The "next-generation" knowledge of papillary thyroid carcinoma 32
High mobility group A1 enhances tumorigenicity of human cholangiocarcinoma and confers resistance to therapy 32
Phosphoprotein enriched in diabetes (PED/PEA15) promotes migration in hepatocellular carcinoma and confers resistance to sorafenib 32
Down-Regulation of the miR-25 and miR-30d Contributes to the Development of Anaplastic Thyroid Carcinoma Targeting the Polycomb Protein EZH2. 31
UbcH10 overexpression is less pronounced in older colorectal cancer patients 31
Oncogenic Properties of the Antisense lncRNA COMET in BRAF- and RET-Driven Papillary Thyroid Carcinomas 30
CDH16/Ksp-Cadherin Is Expressed in the Developing Thyroid Gland and Is Strongly Down-Regulated in Thyroid Carcinomas. 28
HMGA1 protein expression in familial breast carcinoma patients. 27
Liquid biopsy is a promising tool for genetic testing in idiopathic pulmonary fibrosis 27
The Long Non-Coding RNA RP5-1024C24.1 and Its Associated-Gene MPPED2 Are Down-Regulated in Human Thyroid Neoplasias and Act as Tumour Suppressors. 23
CBX7 gene expression plays a negative role in adipocyte cell growth and differentiation 23
null 17
Deregulation of microRNA expression in thyroid neoplasias 17
Elucidation of the CBX7 role in human carcinomas 15
null 11
MPPED2 is downregulated in glioblastoma, and its restoration inhibits proliferation and increases the sensitivity to temozolomide of glioblastoma cells 4
Totale 1.563
Categoria #
all - tutte 5.119
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.119


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201930 0 0 0 0 0 0 0 0 19 5 3 3
2019/2020168 52 1 7 1 16 1 5 28 0 13 33 11
2020/2021127 1 3 17 6 7 19 6 2 10 8 18 30
2021/2022278 4 0 3 1 3 12 1 6 40 34 84 90
2022/2023509 42 48 24 63 57 61 1 51 78 63 13 8
2023/2024272 10 46 29 39 22 79 19 28 0 0 0 0
Totale 1.563